Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant.

Hsu PY, Wu VS, Kanaya N, Petrossian K, Hsu HK, Nguyen D, Schmolze D, Kai M, Liu CY, Lu H, Chu P, Vito CA, Kruper L, Mortimer J, Chen S.

Clin Cancer Res. 2018 Jan 15;24(2):395-406. doi: 10.1158/1078-0432.CCR-17-1983. Epub 2017 Oct 27.

PMID:
29079660
2.

From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?

Wu VS, Kanaya N, Lo C, Mortimer J, Chen S.

J Steroid Biochem Mol Biol. 2015 Sep;153:45-53. doi: 10.1016/j.jsbmb.2015.05.005. Epub 2015 May 18. Review.

3.

Increased expression of epidermal growth factor-receptor in an experimental model of colitis in rats.

Hoffmann P, Reinshagen M, Zeeh JM, Lakshmanan J, Wu VS, Goebell H, Gerken G, Eysselein VE.

Scand J Gastroenterol. 2000 Nov;35(11):1174-80.

PMID:
11145289
4.

Increased expression of transforming growth factor alpha precursors in acute experimental colitis in rats.

Hoffmann P, Zeeh JM, Lakshmanan J, Wu VS, Procaccino F, Reinshagen M, McRoberts JA, Eysselein VE.

Gut. 1997 Aug;41(2):195-202.

7.

The induction of ornithine decarboxylase by tumor promoting phorbol ester analogues in Reuber H35 hepatoma cells.

Wu VS, Byus CV.

Life Sci. 1981 Nov 2;29(18):1855-63. No abstract available.

PMID:
7311719

Supplemental Content

Support Center